Igor I. Slukvin
29Patents
5h-index
23Co-inventors
65Inventor score
Filing activity: May 31, 2006 → Aug 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9938499B2 | Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions | Chemistry; Metallurgy | 21 | Active |
| US7615374B2 | Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions | Chemistry; Metallurgy | 18 | Active |
| US9382531B2 | Induction of hemogenic endothelium from pluripotent stem cells | Chemistry; Metallurgy | 12 | Active |
| US8034613B2 | Multipotent lymphohematopoietic progenitor cells | Chemistry; Metallurgy | 9 | Active |
| US7811821B2 | Method of forming dendritic cells from embryonic stem cells | Chemistry; Metallurgy | 6 | Active |
| US8846395B2 | Generation of mature myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+progenitors | Chemistry; Metallurgy | 3 | Active |
| US8158422B2 | Erythroid cells producing adult-type β-hemoglobin generated from human embryonic stem cells | Chemistry; Metallurgy | 3 | Active |
| US9868939B2 | Generating vasculogenic cell populations | Chemistry; Metallurgy | 3 | Active |
| US8435785B2 | Method of forming dendritic cells from embryonic stem cells | Chemistry; Metallurgy | 2 | Active |
| US9624470B2 | Multipotent lymphohematopoietic progenitor cells | Chemistry; Metallurgy | 2 | Active |
| US8133732B2 | Method of forming myeloid precursor cells from human embryonic stem cells | Chemistry; Metallurgy | 2 | Active |
| US10081792B2 | Derivation of human microglia from pluripotent stem cells | Chemistry; Metallurgy | 2 | Active |
| US11091738B2 | Generating vasculogenic cell populations | Chemistry; Metallurgy | 1 | Active |
| US11124765B2 | Derivation of human microglia from pluripotent stem cells | Chemistry; Metallurgy | 1 | Active |
| US11345895B2 | Induction of arterial-type of hemogenic endothelium (AHE) and enhancement of T cell production from PSCs through overexpression of ETS factors or modulating MAPK/ERK signalling pathways | Chemistry; Metallurgy | 0 | Active |
| US10106771B2 | Induction of hemogenic endothelium from pluripotent stem cells by forced expression of transcription factors | Chemistry; Metallurgy | 0 | Active |
| US10982192B2 | Method for the induction of arterial-type of hemogenic endothelium from hPSCS | Chemistry; Metallurgy | 0 | Active |
| US9771561B2 | Method of making primate cells expressing apelin receptor that have mesangioblast potential | Chemistry; Metallurgy | 0 | Active |
| US9668463B2 | Mouse model for engraftment potential | Human Necessities | 0 | Active |
| US11591571B2 | Pluripotent stem cell assay | Chemistry; Metallurgy | 0 | Active |
| US9765327B2 | Induction of hemogenic endothelium from pluripotent stem cells | Chemistry; Metallurgy | 0 | Active |
| US12410401B2 | Generation of functional neutrophils and macrophages from induced pluripotent stem cells in chemically defined conditions using transient expression of ETV2 | Chemistry; Metallurgy | 0 | Active |
| US9381210B2 | Induced pluripotent stem cell model of chronic myeloid leukemia revealed olfactomedin 4 as a novel therapeutic target in leukemia stem cells | Physics | 0 | Active |
| US12098390B2 | Generating vasculogenic cell populations | Chemistry; Metallurgy | 0 | Active |
| US11174461B2 | Colony forming medium and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.